#$%^&*AU2012318279A120130502.pdf#####CSL BEARING GMBH 2011_MOO6_A182 HAU/kk 12.10.2012 5 Abstract The present invention relates to pharmaceutical preparations comprising one or more Factor Vill and a sulfated glycosaminoglycan for increasing the bioavailability of Factor VIll upon non-intravenous administration. The invention further relates to 10 the combined use of Factor VIII and a sulfated glycosaminoglycan for the treatment and prevention of bleeding disorders, whereby the bioavailability of Factor VIII is increased, and to a method for increasing the bioavailability after non-intravenous administration of Factor VIII by coadminstration of a sulfated glycosaminoglycan.